|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ANZCTR |
|
Last refreshed on:
|
6 February 2017 |
|
Main ID: |
ACTRN12617000189325 |
|
Date of registration:
|
03/02/2017 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Impact of Intermittent fasting in patients with liver fibrosis
|
|
Scientific title:
|
Impact of Intermittent fasting on LDL cholesterol and fibrosis levels in patients with liver fibrosis |
|
Date of first enrolment:
|
22/03/2017 |
|
Target sample size:
|
100 |
|
Recruitment status: |
Not yet recruiting |
|
URL:
|
http://www.anzctr.org.au/ACTRN12617000189325.aspx |
|
Study type:
|
Interventional |
|
Study design:
|
Randomised controlled trial
|
|
Phase:
|
|
|
|
Key inclusion & exclusion criteria
|
|
Health Condition(s) or Problem(s) studied
|
|
Hepatic fibrosis
|
|
Intervention(s)
|
The subjects will perform intermittent fasting during 3 months . Participants will consume no food or drinks asides from the exceptions listed between 20:00 and 13:00 the following day, three days per week for three months.
They could drink some Infusions, water or coffee during the period of voluntary fasting. They can not combine with milk, sweeteners like sugar, saccharin or derivatives.
Participants will fill in a table with their food diary
We´ll do a blood test before the procedure (month 0), during (2 months) and the end of the study (3 months).
|
|
Source(s) of Monetary Support
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|